Ignite Creation Date:
2024-07-17 @ 11:09 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465264
Status:
COMPLETED
Last Update Posted:
2024-06-28
First Post:
2024-06-13
Brief Title:
To Assess Allisartan IsoproxilAmlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine or Allisartan Isoproxil
Sponsor:
Shenzhen Salubris Pharmaceuticals Co Ltd
Organization:
Shenzhen Salubris Pharmaceuticals Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-24
Completion Date Type:
ACTUAL
First Submit Date:
2024-06-13
First Submit QC Date:
None
Study First Post Date:
2024-06-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-26
Last Update Post Date:
2024-06-28
Last Update Post Date Type:
ACTUAL